<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: therapeutic approaches</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Gene variant appears to predict weight loss after gastric bypass</title>
   	 <description>Massachusetts General Hospital (MGH) researchers have identified a gene variant that helps predict how much weight an individual will lose after gastric bypass surgery, a finding with the potential both to guide treatment planning and to facilitate the development of new therapeutic approaches to treating obesity and related conditions like diabetes. The report receiving advance online publication in The American Journal of Human Genetics is the first to identify genetic predictors of weight loss after bariatric surgery.</description>
     <link>http://medicalxpress.com/news/2013-05-gene-variant-weight-loss-gastric.html</link>
	 <category>Genetics</category>
	 <pubDate>Thu, 02 May 2013 12:00:02 EST</pubDate>
	 <guid isPermaLink="false">news286710668</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/geneticfacto.jpg" width="90" height="85" />
</item>
<item>
     <title>Pathological gambling caused by excessive optimism</title>
   	 <description>Compulsive gamblers suffer from an optimism bias that modifies their subjective representation of probability and affects their decisions in situations involving high-risk monetary wagers. This is the conclusion drawn by Jean-Claude Dreher's research team at the CNC (Centre de Neurosciences Cognitives, CNRS / Université Claude Bernard Lyon). These findings, published in the May print edition of Psychological Medicine, could help explain and anticipate certain individuals' vulnerability to gambling, and could lead to new therapeutic approaches.</description>
     <link>http://medicalxpress.com/news/2013-04-pathological-gambling-excessive-optimism.html</link>
	 <category>Psychology &amp; Psychiatry</category>
	 <pubDate>Tue, 30 Apr 2013 09:25:49 EST</pubDate>
	 <guid isPermaLink="false">news286532741</guid>
	 
</item>
<item>
     <title>Team finds melatonin delays ALS symptom onset and death in mice</title>
   	 <description>Melatonin injections delayed symptom onset and reduced mortality in a mouse model of the neurodegenerative condition amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to a new study by researchers at the University of Pittsburgh School of Medicine. In a report published online ahead of print in the journal Neurobiology of Disease, the team revealed that receptors for melatonin are found in the nerve cells, a finding that could launch novel therapeutic approaches.</description>
     <link>http://medicalxpress.com/news/2013-04-team-melatonin-als-symptom-onset.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Thu, 25 Apr 2013 04:54:11 EST</pubDate>
	 <guid isPermaLink="false">news286084445</guid>
	 
</item>
<item>
     <title>Study uncovers key factor in Alzheimer's progression</title>
   	 <description>(Medical Xpress)—A new study from researchers at the University of Florida may have uncovered a critical factor that drives the relentless progression of Alzheimer's disease ― a discovery that could eventually slow its progression.</description>
     <link>http://medicalxpress.com/news/2013-04-uncovers-key-factor-alzheimer.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Tue, 16 Apr 2013 06:10:01 EST</pubDate>
	 <guid isPermaLink="false">news285310460</guid>
	 
</item>
<item>
     <title>Scientists identify molecular system that could help develop potential treatments for neurodegenerative diseases</title>
   	 <description>Scientists from the University of Southampton have identified the molecular system that contributes to the harmful inflammatory reaction in the brain during neurodegenerative diseases.</description>
     <link>http://medicalxpress.com/news/2013-02-scientists-molecular-potential-treatments-neurodegenerative.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Thu, 21 Feb 2013 08:42:01 EST</pubDate>
	 <guid isPermaLink="false">news280658504</guid>
	 
</item>
<item>
     <title>Kidney disease mutations found in a genomic blind spot</title>
   	 <description>(Medical Xpress)—Advances in DNA sequencing technology during the past decade have given scientists powerful tools to peer into the genomes of humans and other species. Despite the efficiency and sophistication of these technologies – known as massively parallel, or next-generation, sequencers – some of the genome's secrets still remain hidden.</description>
     <link>http://medicalxpress.com/news/2013-02-kidney-disease-mutations-genomic.html</link>
	 <category>Genetics</category>
	 <pubDate>Mon, 11 Feb 2013 08:10:08 EST</pubDate>
	 <guid isPermaLink="false">news279792597</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/kidneydiseas.jpg" width="90" height="90" />
</item>
<item>
     <title>Calcium-binding protein mutations found in heart rhythm disorders</title>
   	 <description>A team led by Vanderbilt University investigators has discovered two new genes – both coding for the signaling protein calmodulin – associated with severe early-onset disorders of heart rhythm. The findings, reported online Feb. 6 in the journal Circulation, expand the list of culprits that can cause sudden cardiac death and may point to new therapeutic approaches.</description>
     <link>http://medicalxpress.com/news/2013-02-calcium-binding-protein-mutations-heart-rhythm.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 06 Feb 2013 13:00:13 EST</pubDate>
	 <guid isPermaLink="false">news279377526</guid>
	 
</item>
<item>
     <title>Researchers discover genetic basis for eczema, new avenue to therapies</title>
   	 <description>(Medical Xpress)—Researchers at Oregon State University today announced the discovery of an underlying genetic cause of atopic dermatitis, a type of eczema most common in infancy that also affects millions of adults around the world with dry, itchy and inflamed skin lesions.</description>
     <link>http://medicalxpress.com/news/2012-12-genetic-basis-eczema-avenue-therapies.html</link>
	 <category>Inflammatory disorders</category>
	 <pubDate>Fri, 21 Dec 2012 13:14:21 EST</pubDate>
	 <guid isPermaLink="false">news275318051</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/110-researchersd.jpg" width="90" height="90" />
</item>
<item>
     <title>American Society of Clinical Oncology issues annual report on state of clinical cancer science</title>
   	 <description>The American Society of Clinical Oncology (ASCO) has just released its annual report on the top cancer advances of the year. Clinical Cancer Advances 2012: ASCO's Annual Report on Progress Against Cancer, highlights major achievements in precision medicine, cancer screening and overcoming treatment resistance.</description>
     <link>http://medicalxpress.com/news/2012-12-american-society-clinical-oncology-issues.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 03 Dec 2012 16:00:12 EST</pubDate>
	 <guid isPermaLink="false">news273757673</guid>
	 
</item>
<item>
     <title>Computer model enables better understanding of what happens during and after stroke</title>
   	 <description>(Medical Xpress)—At the moment that someone is suffering a stroke, the immediate concern is getting them stabilized. Once the initial attack has passed, additional treatment and preventive measures can be implemented. Understanding what's happening during the actual event, and in the subsequent hours and days, will help improve the effectiveness of the post-attack treatment plan, and also help identify methods of neuroprotection—that is, administer treatments to protect against a stroke in advance for potentially at-risk individuals. Computational biology researchers at Pacific Northwest National Laboratory developed a model for predicting what's happening during a stroke, how the process evolves over time, the potential outcomes, and the effects of different treatment options.</description>
     <link>http://medicalxpress.com/news/2012-11-enables.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 27 Nov 2012 07:10:45 EST</pubDate>
	 <guid isPermaLink="false">news273222561</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/1-computermode.jpg" width="90" height="98" />
</item>
<item>
     <title>Controlling vascular disease may be key to reducing prevalence of Alzheimer's disease</title>
   	 <description>Over the last 15 years, researchers have found a significant association between vascular diseases such as hypertension, atherosclerosis, diabetes type 2, hyperlipidemia, and heart disease and an increased risk of Alzheimer's disease. In a special issue of the Journal of Alzheimer's Disease, leading experts provide a comprehensive overview of the pathological, biochemical, and physiological processes that contribute to Alzheimer's disease risk and ways that may delay or reverse these age-related abnormalities.</description>
     <link>http://medicalxpress.com/news/2012-11-vascular-disease-key-prevalence-alzheimer.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Mon, 05 Nov 2012 16:45:12 EST</pubDate>
	 <guid isPermaLink="false">news271356276</guid>
	 
</item>
<item>
     <title>A Viagra follow-up? Drug used to treat glaucoma actually grows human hair</title>
   	 <description>If you're balding and want your hair to grow back, then here is some good news. A new research report appearing online in The FASEB Journal  shows how the FDA-approved glaucoma drug, bimatoprost, causes human hair to regrow. It's been commercially available as a way to lengthen eyelashes, but these data are the first to show that it can actually grow human hair from the scalp.</description>
     <link>http://medicalxpress.com/news/2012-10-viagra-follow-up-drug-glaucoma-human.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 26 Oct 2012 12:52:03 EST</pubDate>
	 <guid isPermaLink="false">news270474673</guid>
	 
</item>
<item>
     <title>EPFL and Harvard join forces to diagnose hearing loss</title>
   	 <description>Researchers at EPFL and Harvard Medical School have joined forces to develop an imaging technique that can provide in situ observations of the internal ear, an area which has until now been inaccessible. This groundbreaking work may finally make it possible to understand the mechanisms underlying hearing loss.</description>
     <link>http://medicalxpress.com/news/2012-10-epfl-harvard-loss.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 17 Oct 2012 08:34:14 EST</pubDate>
	 <guid isPermaLink="false">news269681647</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/epflandharva.jpg" width="90" height="90" />
</item>
<item>
     <title>Researchers discover new blood vessel-generating cell with therapeutic potential</title>
   	 <description>Researchers at the University of Helsinki believe they have discovered stem cells that play a decisive role in the growth of new blood vessels. If researchers learn to isolate and efficiently produce these stem cells found in blood vessel walls, the cells could offer new opportunities for developing therapeutics to treat diseases, such as cardiovascular disease and cancer. The study reporting the discovery of these stem cells is published in the open access journal PLOS Biology on October 16.</description>
     <link>http://medicalxpress.com/news/2012-10-blood-vessel-generating-cell-therapeutic-potential.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 16 Oct 2012 17:00:16 EST</pubDate>
	 <guid isPermaLink="false">news269624133</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/finnishresea.jpg" width="90" height="90" />
</item>
<item>
     <title>Aggressive cancer exploits MYC oncogene to amplify global gene activity</title>
   	 <description>Whitehead Institute researchers have determined the mechanism used by c-Myc to increase the expression of all active genes in cancer cells. Elevated levels of c-Myc are linked to increased rates of metastasis, disease recurrence, and mortality in cancer patients. Guided by this new model, researchers hope to find ways to restrict c-Myc's activity to eradicate cancer cells that become dependent on c-Myc for their survival.</description>
     <link>http://medicalxpress.com/news/2012-09-aggressive-cancer-exploits-myc-oncogene.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 27 Sep 2012 12:00:08 EST</pubDate>
	 <guid isPermaLink="false">news267964972</guid>
	 
</item>
<item>
     <title>Researchers prevent heart failure in mice</title>
   	 <description>(Medical Xpress)—Cardiac stress, for example a heart attack or high blood pressure, frequently leads to pathological heart growth and subsequently to heart failure. Two tiny RNA molecules play a key role in this detrimental development in mice, as researchers at the Hannover Medical School and the Göttingen Max Planck Institute for Biophysical Chemistry have now discovered. When they inhibited one of those two specific molecules, they were able to protect the rodent against pathological heart growth and failure. With these findings, the scientists hope to be able to develop therapeutic approaches that can protect humans against heart failure.</description>
     <link>http://medicalxpress.com/news/2012-09-heart-failure-mice.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 25 Sep 2012 16:54:12 EST</pubDate>
	 <guid isPermaLink="false">news267810840</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/17-researchersp.jpg" width="90" height="90" />
</item>
<item>
     <title>New molecule with anti-cancer and anti-metastatic properties</title>
   	 <description>A new molecule with anti-cancer and anti-metastatic properties has been discovered by teams from CNRS, CEA, the Institut Curie and Inserm, in collaboration with Australian and British researchers. This anticancer drug acts on cells resistant to conventional chemotherapy thanks to an entirely novel action mechanism. It targets not only the multiplication of cells but also their mobility and thus could prevent the formation of metastases. Published in Cancer Research, the results obtained in vitro and on animals could, in the medium term, lead to the development of alternative anti-cancer treatments.</description>
     <link>http://medicalxpress.com/news/2012-09-molecule-anti-cancer-anti-metastatic-properties.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 04 Sep 2012 17:33:10 EST</pubDate>
	 <guid isPermaLink="false">news265998783</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/y5edu5e65.jpg" width="90" height="90" />
</item>
<item>
     <title>Scientists use worms to unearth cancer drug targets</title>
   	 <description>Through novel experiments involving small nematode worms, scientists from Wyoming have discovered several genes that may be potential targets for drug development in the ongoing war against cancer. Specifically, researchers hypothesize that inhibiting these genes could reverse certain key traits associated with cancer cells. This discovery is published in the August 2012 issue of the Genetics Society of America's journal GENETICS.</description>
     <link>http://medicalxpress.com/news/2012-08-scientists-worms-unearth-cancer-drug.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 09 Aug 2012 11:28:05 EST</pubDate>
	 <guid isPermaLink="false">news263730476</guid>
	 
</item>
<item>
     <title>Scientists explore molecular link between arsenic exposure and lung cancer</title>
   	 <description>Arsenic is a natural element in the environment, sometimes found in air, soil and water. Arsenic contaminated water is a global threat, currently affecting more than 100 million people. Both genetic and epigenetic changes drive arsenic-induced carcinogenesis and lung cancer is one of the main consequences of this process.</description>
     <link>http://medicalxpress.com/news/2012-07-scientists-explore-molecular-link-arsenic.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 25 Jul 2012 14:00:01 EST</pubDate>
	 <guid isPermaLink="false">news262439549</guid>
	 
</item>
<item>
     <title>Identification of a novel target for glioblastoma treatment</title>
   	 <description>(Medical Xpress) -- A recent study from scientists at the Friedrich Miescher Institute for Biomedical Research has identified a novel target for the treatment of malignant brain tumors. The scientists found that the Mer receptor tyrosine kinase (MerTK) is highly expressed in human brain tumors but absent from normal adult brain tissue. MerTK not only increases the invasive potential of brain tumor-derived cells but also promotes their survival when treated with chemotherapeutics. Conversely, the authors demonstrate that loss of MerTK strongly reduces the invasive capacity of tumor cells, making it an attractive target for future brain tumor therapies.</description>
     <link>http://medicalxpress.com/news/2012-06-identification-glioblastoma-treatment.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 18 Jun 2012 09:00:01 EST</pubDate>
	 <guid isPermaLink="false">news259225943</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/identificati.jpg" width="90" height="90" />
</item>
<item>
     <title>Chronic pain is relieved by cell transplantation in lab study (Update)</title>
   	 <description>(Medical Xpress) -- Chronic pain, by definition, is difficult to manage, but a new study by UCSF scientists shows how a cell therapy might one day be used not only to quell some common types of persistent and difficult-to-treat pain, but also to cure the conditions that give rise to them.</description>
     <link>http://medicalxpress.com/news/2012-05-pain-transplants.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Wed, 23 May 2012 13:20:19 EST</pubDate>
	 <guid isPermaLink="false">news256998014</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/chronicpaini.jpg" width="90" height="90" />
</item>
<item>
     <title>Combination treatment in mice shows promise for fatal neurological disorder in kids</title>
   	 <description>Infants with Batten disease, a rare but fatal neurological disorder, appear healthy at birth. But within a few short years, the illness takes a heavy toll, leaving children blind, speechless and paralyzed. Most die by age 5.</description>
     <link>http://medicalxpress.com/news/2012-03-combination-treatment-mice-fatal-neurological.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Thu, 15 Mar 2012 16:47:48 EST</pubDate>
	 <guid isPermaLink="false">news251048849</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/combinationt.jpg" width="90" height="88" />
</item>
<item>
     <title>Researchers develop first 'theranostic' treatment for acute lymphoblastic leukemia (ALL)</title>
   	 <description>A team of researchers at Case Western Reserve University School of Medicine has developed the first &quot;theranostic&quot; agent for the treatment of acute lymphoblastic leukemia (ALL). ALL is the most common type of childhood cancer diagnosed in approximately 5,000 new cases each year in the United States. The findings provide insight into pediatric oncology that specifically focuses on the development of &quot;theranostic&quot; agents-- a treatment platform that combines a selective diagnostic test with targeted therapy based on the test results.</description>
     <link>http://medicalxpress.com/news/2012-03-theranostic-treatment-acute-lymphoblastic-leukemia.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 07 Mar 2012 15:38:03 EST</pubDate>
	 <guid isPermaLink="false">news250357076</guid>
	 
</item>
<item>
     <title>New clues to muscle wasting in elderly people</title>
   	 <description>Permanent disconnection between nerves and muscles may be the reason behind progressive loss of muscle mass and function in elderly people, Perth-based researchers have found.</description>
     <link>http://medicalxpress.com/news/2012-02-clues-muscle-elderly-people.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 24 Feb 2012 07:00:01 EST</pubDate>
	 <guid isPermaLink="false">news249288240</guid>
	 
</item>
<item>
     <title>A thought-provoking new therapeutic target for brain cancer?</title>
   	 <description>Glioblastoma multiforme (GBM) is the most common of all malignant brain tumors that originate in the brain. Patients with GBM have a poor prognosis because it is a highly aggressive form of cancer that is commonly resistant to current therapies. New therapeutic approaches are therefore much needed. Joanna Phillips, Zena Werb, and colleagues, at the University of California, San Francisco, have now identified a potential new therapeutic target for the treatment of GBM.</description>
     <link>http://medicalxpress.com/news/2012-02-thought-provoking-therapeutic-brain-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 01 Feb 2012 13:13:53 EST</pubDate>
	 <guid isPermaLink="false">news247324419</guid>
	 
</item>
<item>
     <title>Transcriptional barcoding of retinal cells identifies disease target cells</title>
   	 <description>(Medical Xpress) -- By developing a large scale gene expression map for retinal cell types, FMI Neurobiologists have been able to identify the cells in the retina, where the genes causing retinal diseases specifically act. This narrows down the search for a better understanding of the diseases and opens up new avenues for therapeutic approaches.</description>
     <link>http://medicalxpress.com/news/2012-01-transcriptional-barcoding-retinal-cells-disease.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 23 Jan 2012 05:49:37 EST</pubDate>
	 <guid isPermaLink="false">news246520165</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/transcriptio.jpg" width="90" height="90" />
</item>
<item>
     <title>Novel treatment protects mice against malaria; approach may work in humans as well</title>
   	 <description>Malaria is a major global health concern, and researchers are in need of new therapeutic approaches. To address this concern, a study published Oct. 26 in the online journal PLoS ONE reveals new information about the host cell's treatment of the parasite that causes the disease in mice, opening potential new avenues for research and treatment.</description>
     <link>http://medicalxpress.com/news/2011-10-treatment-mice-malaria-approach-humans.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 26 Oct 2011 17:31:48 EST</pubDate>
	 <guid isPermaLink="false">news238869096</guid>
	 
</item>
<item>
     <title>Scientists find new mutations in leukemia</title>
   	 <description>An international team of researchers has found a group of mutations involved in T-cell acute lymphoblastic leukemia (T-ALL), and showed that certain drugs, already in clinical use to treat other diseases, can eliminate the cells carrying these mutations.</description>
     <link>http://medicalxpress.com/news/2011-09-scientists-mutations-leukemia.html</link>
	 <category>Genetics</category>
	 <pubDate>Sun, 04 Sep 2011 13:00:02 EST</pubDate>
	 <guid isPermaLink="false">news234359885</guid>
	 
</item>
<item>
     <title>Men's and women's immune systems respond differently to PTSD</title>
   	 <description>Men and women had starkly different immune system responses to chronic post-traumatic stress disorder, with men showing no response and women showing a strong response, in two studies by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.</description>
     <link>http://medicalxpress.com/news/2011-04-men-women-immune-differently-ptsd.html</link>
	 <category>Psychology &amp; Psychiatry</category>
	 <pubDate>Tue, 26 Apr 2011 15:23:00 EST</pubDate>
	 <guid isPermaLink="false">news223050140</guid>
	 
</item>


</channel>
</rss>
